首頁 > 市場調查報告書 > 醫療設備

導管泌尿科

市場調查報告書

商品編碼

1776212

留置型導管的全球市場 - 市場考察，競爭情形，市場預測(2032年)

Indwelling Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日期: 2025年07月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球留置導尿管市場預計將從 2024 年的 15.4611 億美元成長至 2032 年的 28.8019 億美元，2025 年至 2032 年的複合年增長率為 8.14%。尿失禁和尿瀦留等泌尿系統疾病的盛行率不斷上升，推動了對有效管理這些疾病的留置導尿管的需求。此外，人們對微創手術的日益青睞也進一步推動了這些導尿管的應用，它們為泌尿系統管理提供了微創解決方案。此外，外科手術（尤其是泌尿科和術後護理）的增加也為該市場做出了重大貢獻。此外，透過篩檢計畫提高公眾認知有助於及早發現和治療泌尿系統疾病，從而推動了對導尿管的需求。此外，各大公司持續開發旨在提升安全性、舒適性和預防感染的產品，也支撐著市場的成長，使留置導尿管成為臨床和家庭環境中的首選方案。預計這些因素將在2025年至2032年的預測期內推動留置導尿管市場的發展。

留置導尿管市場動態

根據澳洲尿失禁基金會（2024年）的最新數據，高達10%的澳洲男性和高達38%的澳洲女性患有尿失禁。尿失禁患者需要有效的管理方案來維持生活品質。對於嚴重尿失禁的患者來說，留置導尿管是一個實用的選擇，可以幫助他們謹慎舒適地管理病情。留置導尿管（例如 Foley 導尿管）已成為嚴重尿失禁患者的必備工具，因為它們提供了可靠且舒適的排尿方式，從而推動了全球留置導尿管市場的整體成長。

此外，根據 GLOBOCAN (2024) 提供的最新數據，預計 2022 年全球新增膀胱癌病例數將達到 61.4 萬例，到 2045 年將增加 112 萬例。膀胱癌患者通常接受各種治療，包括手術和化療，並且在復健和安寧療護期間可能需要留置導尿管進行排尿管理。這些導尿管提供可靠的排尿方式，緩解不適，並預防尿瀦留和感染等併發症。

留置導尿管需求的另一個重要驅動因素是外科手術的增加。外科手術被視為急性護理，既定的規程規定病人在術後必須休息。手術的原因多種多樣，包括創傷、器械植入和腫瘤切除。根據世界銀行集團2022年的數據，德國每10萬人約有19,124例手術。芬蘭同年每10萬人約有15,870例手術。同時，中國香港在2023年每10萬人約有1,735例手術。

此外，根據全球外科基金會2021年的報告，全球約30%的疾病負擔是由可透過手術治療的疾病造成的。因此，預計手術數量的增加將進一步推動留置導管的需求，並支持未來的市場成長。

此外，主要市場參與者正在進行的策略活動正在進一步推動全球整體留置導管市場的發展。例如，2022年12月，尿道（Foley）智慧導尿管固定裝置的創新開發商CATHETRIX在2023年1月至2月於阿聯酋杜拜舉行的2023年阿拉伯衛生展覽會上，商業化推出了一款旨在預防尿路感染（UTI）和Foley導尿管意外移除的導尿管穩定移除的導尿管。

預計上述因素將在預測期內提振全球留置導尿管市場的整體成長。

然而，導尿管相關泌尿道感染（CAUTI）的風險和產品回收的增加可能會阻礙留置導尿管市場未來的成長。

本報告對全球留置導尿管市場進行了研究和分析，提供了市場規模和預測、過去三年的產品和技術發展、主要市場參與者以及可用機會等資訊。

BD
Cardinal Health
ConvaTec Inc.
Teleflex Incorporated
Coloplast
B. Braun Melsungen AG
Medtronic
Well Lead Medical Co., Ltd.
Smiths Medical
BACTIGUARD AB
Shenzhen Prunus Medical Co., Ltd.
Optimum Medical Limited
Angiplast
Guangzhou Orcl Medical Co., Ltd.
Apollon Co., Ltd.
The Flume Catheter Company
MEDADV Medical
Otsuka Pharmaceutical Factory, Inc.
CATHETRIX
Flume Catheter Company

第9章 KOL的見解

第10章計劃方法

第11章關於DelveInsight

第12章免責聲明，諮詢方式

簡介目錄圖表

Product Code: DIMDCL0323

Indwelling Catheters Market by Product Type (2-Way, 3-Way, and 4-Way), Material (Silicone, Latex, and Poly Vinyl Chloride), Tip Type (Straight and Coude/Tienmann), Age Group (Adult and Pediatric), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of urinary disorders, increasing volume of surgical procedures, rising awareness and screening programs, and increase in product development activities by key market players across the globe.

The indwelling catheters market was valued at USD 1,546.11 million in 2024, growing at a CAGR of 8.14% during the forecast period from 2025 to 2032 to reach USD 2,880.19 million by 2032. The rising prevalence of urinary disorders, such as incontinence and retention, is driving demand for indwelling catheters to manage these conditions effectively. Furthermore, the increasing preference for minimally invasive procedures has further bolstered the adoption of these catheters, as they offer a less invasive solution for urinary management. Additionally, the growing volume of surgical procedures, especially in urology and postoperative care, also contributes significantly to the market. Moreover, increased awareness through screening programs encourages early detection and treatment of urinary issues, boosting catheter demand. Furthermore, ongoing product development by key players to enhance safety, comfort, and infection prevention has supported market growth, making indwelling catheters a preferred choice in both clinical and home settings. Collectively, these factors are expected to boost the market for indwelling catheters during the forecast period from 2025 to 2032.

Indwelling Catheters Market Dynamics:

According to recent data provided by the Continence Foundation of Australia (2024), urinary incontinence affected up to 10% of Australian men and up to 38% of Australian women. Individuals suffering from urinary incontinence require effective management solutions to maintain quality of life. Indwelling catheters serve as a practical option for patients experiencing severe incontinence, enabling them to manage their condition discreetly and comfortably. Indwelling catheters, such as Foley catheters, offer a reliable and comfortable method for urine drainage, making them an essential tool for patients with severe incontinence thereby boosting the overall market of indwelling catheters across the globe.

Additionally, as per the recent data provided by GLOBOCAN (2024), in 2022, the estimated number of new cases of bladder cancer was 614,000 and the projections were estimated to increase by 1.12 million by 2045 globally. As bladder cancer patients often undergo various treatments, including surgery and chemotherapy, they may require indwelling catheters for urinary management during recovery or palliative care. These catheters provide a reliable means of urine drainage, alleviating discomfort and preventing complications such as urinary retention and infections.

Another key factor in boosting the demand for indwelling catheters is the increasing number of surgical procedures. Surgical procedures are considered as acute care and as an established protocol, patients are advised bed rest after surgery. Surgeries may be performed in events of trauma cases, for device implantation and tumor removal among other factors. According to recent data from the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population. Finland recorded 15,870 surgical procedures per 100,000 population in the same year. In contrast, Hong Kong, China, had 1,735 surgical procedures per 100,000 population in 2023.

Additionally, according to the Global Surgery Foundation 2021 reports, about 30% of the global burden of disease is caused by conditions that can be treated by surgery. Thus, the increasing number of surgical procedures are further expected to drive the demand for indwelling catheters, thereby supporting the market growth in the coming years.

Moreover, the ongoing strategic activities among the key market players are further boosting the overall market of indwelling catheters across the globe. For instance, in December 2022, CATHETRIX, an innovative developer of urinary (Foley) smart catheter fixation devices, commercially launched its catheter stabilizer aimed at preventing urinary tract infections (UTIs) and accidental Foley catheter extractions at Arab Health 2023, held from January to February 2023, in Dubai, UAE.

Therefore, the factors mentioned above are expected to boost the overall market of indwelling catheters across the globe during the forecast period.

However, the risk of catheter-associated urinary tract infections (CAUTI) and increased product recalls may hinder the future market of indwelling catheters market growth.

Indwelling Catheters Market Segment Analysis:

In the tip type segment of the indwelling catheter market, the straight category is expected to hold the largest share in the year 2024. Straight-tip indwelling catheters can significantly boost the overall market of indwelling catheters by addressing specific clinical needs and improving patient outcomes. These catheters are designed for a range of urological applications, particularly in patients who require intermittent catheterization or those with specific anatomical considerations, such as urethral strictures or abnormalities. Their straight-tip design allows for easier insertion and manipulation, reducing trauma to the urethra and minimizing the risk of complications such as urethral injury or discomfort during insertion.

Moreover, straight-tip catheters can be particularly beneficial in pediatric and female populations where anatomical variations may pose challenges with standard catheters. The increasing prevalence of urinary disorders, combined with a growing awareness of the benefits of minimizing catheter-associated complications, propels the demand for these specialized catheters.

Additionally, the advancement of materials used in the manufacture of straight-tip indwelling catheters such as hydrophilic coatings enhances patient comfort and reduces friction during insertion, further encouraging adoption among healthcare providers. As healthcare systems shift towards more patient-centered care, the convenience, safety, and effectiveness of straight-tip indwelling catheters contribute to their rising popularity, thereby expanding their market share within the broader indwelling catheter market. The ongoing development and innovation in this segment, including the introduction of smart catheters that incorporate features to monitor urinary output and prevent infections, are also expected to drive growth by meeting the evolving needs of clinicians and patients alike.

Overall, the increasing awareness of the benefits and specific applications of straight-tip indwelling catheters is likely to stimulate market expansion, making them a vital component of the indwelling catheter landscape.

North America is expected to dominate the overall indwelling catheters market:

Among all the regions, North America is expected to hold the largest share of the global indwelling catheter market in 2024. The key driving factors of the indwelling catheter market are the increasing prevalence of urological disorders such as bladder cancers, benign prostatic hyperplasia, and urinary retention, an increase in surgical procedures as well as a growing focus on product development activities in the region. These factors are expected to boost the market of indwelling catheters across the region during the forecasted period.

According to recent data from Johns Hopkins (2024), over 25 million adult Americans experience temporary or chronic urinary incontinence. Indwelling catheters provide an effective solution for continuous urine drainage, helping patients manage incontinence and improve their quality of life. The rising awareness of treatment options and the need for long-term care solutions, especially in home healthcare and assisted living settings, are driving the demand for indwelling catheters across the region.

Additionally, according to the recent data provided by GLOBOCAN (2024), in 2022, the estimated number of new cases of bladder cancer in North America was 95,500 and the projections were estimated to increase by 150,000 by 2045. It has been reported that bladder cancer may cause changes in urination such as having to urinate more, fullness in the bladder, and pain and burning during urination. In such events, indwelling catheters are employed for patients who feel incapacitated in voiding the bladder due to physical inability. Therefore, the increase in the prevalence of bladder cancer may drive the demand for indwelling catheters in the coming years.

According to the data provided by the Christopher & Dana Reeve Foundation (2025), the annual incidence of spinal cord injury (SCI) was approximately 54 cases per one million people in the United States, or about 18,000 new SCI cases each year. It has been established that in a SCI, bladder sphincter relaxation is absent, leading to urinary retention. This is then treated with the deployment of indwelling catheters. Thus, the growing incidence of SCI over time is expected to drive the demand for indwelling catheters in the country, eventually driving the indwelling catheters market in North America.

Furthermore, extensive product development activities in the region, specifically in the United States also help in driving the product demand in the region. For instance, in November 2021, the Flume Catheter Company received 510k product approval from the US Food and Drug Administration for their new indwelling urinary catheter which features an advanced balloon design.

Therefore, the factors mentioned above in the region are expected to boost the North America indwelling catheters market during the forecast period.

Indwelling Catheters Market Key Players:

Some of the key market players operating in the indwelling catheters market include BD, Cardinal Health, ConvaTec Inc., Teleflex Incorporated, Coloplast, B. Braun Melsungen AG, Medtronic PLC, Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, Shenzhen Prunus Medical Co., Ltd., Optimum Medical Limited, Angiplast, Guangzhou Orcl Medical Co., Ltd., Apollon Co., Ltd., The Flume Catheter Company, MEDADV Medical, Otsuka Pharmaceutical Factory, Inc., CATHETRIX, Flume Catheter Company, and others.

Recent Developmental Activities in the Indwelling Catheters Market:

In December 2023, Bactiguard Holding AB announced strengthened ties with Becton Dickinson & Company (BD), signing an interim agreement granting BD an exclusive global license for Bactiguard-coated Foley catheters, as part of the strategy to phase out Bactiguard's medical device portfolio.
In January 2023, Bactiguard received the first MDR product approval for their BIP Foley Catheter.

Key takeaways from the indwelling catheters market report study:

Market size analysis for current indwelling catheters size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the indwelling catheters market.
Various opportunities available for the other competitors in the indwelling catheters market space.
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current indwelling catheters market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for indwelling catheter market growth in the coming future?

Target audience who can benefit from this indwelling catheters market report study:

Indwelling catheter product providers
Research organizations and consulting companies
Indwelling catheters -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in indwelling catheters
Various end-users who want to know more about the indwelling catheters market and the latest technological developments in the indwelling catheters market.

Frequently Asked Questions for the Indwelling Catheters Market:

1. What are indwelling catheters?

An indwelling catheter is also known as a Foley catheter. The catheter is held in the bladder by a water-filled balloon that helps in keeping the catheter from falling out and helps in creating an outlet for the passing of urine.

2. What is the market for indwelling catheters?

The indwelling catheters market was valued at USD 1,546.11 million in 2024, growing at a CAGR of 8.14% during the forecast period from 2025 to 2032 to reach USD 2,880.19 million by 2032.

3. What are the drivers for the indwelling catheters market?

The rising prevalence of urinary disorders, such as incontinence and retention, is driving demand for indwelling catheters to manage these conditions effectively. Furthermore, the increasing preference for minimally invasive procedures has further bolstered the adoption of these catheters, as they offer a less invasive solution for urinary management. Additionally, the growing volume of surgical procedures, especially in urology and postoperative care, also contributes significantly to the market. Moreover, increased awareness through screening programs encourages early detection and treatment of urinary issues, boosting catheter demand. Furthermore, ongoing product development by key players to enhance safety, comfort, and infection prevention has supported market growth, making indwelling catheters a preferred choice in both clinical and home settings. Collectively, these factors are expected to boost the market for indwelling catheters during the forecast period from 2025 to 2032.

4. Who are the key players operating in the indwelling catheters market?

Some of the key market players operating in the Indwelling Catheters market include BD, Cardinal Health, ConvaTec Inc., Teleflex Incorporated, Coloplast, B. Braun Melsungen AG, Medtronic PLC, Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, Shenzhen Prunus Medical Co., Ltd., Optimum Medical Limited, Angiplast, Guangzhou Orcl Medical Co., Ltd., Apollon Co., Ltd., The Flume Catheter Company, MEDADV Medical, Otsuka Pharmaceutical Factory, Inc., CATHETRIX, Flume Catheter Company, and others.

5. Which region has the highest share in the indwelling catheters market?

Among all the regions, North America is expected to hold the largest share of the global indwelling catheter market in 2024. The key driving factors of the indwelling catheter market are the increasing prevalence of urological disorders such as bladder cancers, benign prostatic hyperplasia, and urinary retention, an increase in surgical procedures as well as a growing focus on product development activities in the region. These factors are expected to boost the market of indwelling catheters across the region during the forecasted period.

1. Indwelling Catheters Market Report Introduction

1.1 Scope of the Study
1.2 Market Segmentation
1.3 Market Assumption

2. Indwelling Catheters Market Executive Summary

2.1 Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1 The United States
4.2 Europe
4.3 Japan
4.4 China

5. Indwelling Catheters Market Key Factors Analysis

5.1. Indwelling Catheters Market Drivers
- 5.1.1 The rising prevalence of urinary disorders
- 5.1.2 Increasing volume of surgical procedures
- 5.1.3 Rising awareness and screening programs
- 5.1.4 Increase in product development activities by key market players across the globe.
5.2 Indwelling Catheters Market Restraints and Challenges
- 5.2.1 Risk of catheter-associated urinary tract infections (CAUTI)
- 5.2.2 Increase in product recalls
5.3 Indwelling Catheters Market Opportunities
- 5.3.1 Ongoing improvement in the safety prospects of indwelling catheters

6. Indwelling Catheters Market Porter's Five Forces Analysis

6.1 Bargaining Power of Suppliers
6.2 Bargaining Power of Consumers
6.3 Threat of New Entrants
6.4 Threat of Substitutes
6.5 Competitive Rivalry

7. Indwelling Catheters Market Assessment

7.1 By Product Type
- 7.1.1 2-Way
- 7.1.2 3-Way
- 7.1.3 4-Way
7.2 By Material
- 7.2.1 Silicone
- 7.2.2 Latex
- 7.2.3 Poly Vinyl Chloride
7.3 By Tip Type
- 7.3.1 Straight
- 7.3.2 Coude/Tienmann
7.4 By Age Group
- 7.4.1 Adult
- 7.4.2 Pediatric
7.5 By End-User
- 7.5.1 Hospitals
- 7.5.2 Specialty Clinics
- 7.5.3 Others
7.6 By Geography
- 7.6.1 North America
  - 7.6.1.1 United States Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.1.2 Canada Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.1.3 Mexico Indwelling Catheters Market Size in USD million (2022-2032)
- 7.6.2 Europe
  - 7.6.2.1 France Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.2.2 Germany Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.2.3 United Kingdom Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.2.4 Italy Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.2.5 Spain Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.2.6 Rest of Europe Indwelling Catheters Market Size in USD million (2022-2032)
- 7.6.3 Asia-Pacific
  - 7.6.3.1 China Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.3.2 Japan Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.3.3 India Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.3.4 Australia Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.3.5 South Korea Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.3.6 Rest of Asia-Pacific Indwelling Catheters Market Size in USD million (2022-2032)
- 7.6.4 Rest of the World (RoW)
  - 7.6.4.1 Middle East Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.4.2 Africa Indwelling Catheters Market Size in USD million (2022-2032)
  - 7.6.4.3 South America Indwelling Catheters Market Size in USD million (2022-2032)

8. Indwelling Catheters Market Company and Product Profiles

8.1 BD
- 8.1.1 Company Overview
- 8.1.2 Company Snapshot
- 8.1.3 Financial Overview
- 8.1.4 Product Listing
- 8.1.5 Entropy
8.2 Cardinal Health
- 8.2.1 Company Overview
- 8.2.2 Company Snapshot
- 8.2.3 Financial Overview
- 8.2.4 Product Listing
- 8.2.5 Entropy
8.3 ConvaTec Inc.
- 8.3.1 Company Overview
- 8.3.2 Company Snapshot
- 8.3.3 Financial Overview
- 8.3.4 Product Listing
- 8.3.5 Entropy
8.4 Teleflex Incorporated
- 8.4.1 Company Overview
- 8.4.2 Company Snapshot
- 8.4.3 Financial Overview
- 8.4.4 Product Listing
- 8.4.5 Entropy
8.5 Coloplast
- 8.5.1 Company Overview
- 8.5.2 Company Snapshot
- 8.5.3 Financial Overview
- 8.5.4 Product Listing
- 8.5.5 Entropy
8.6 B. Braun Melsungen AG
- 8.6.1 Company Overview
- 8.6.2 Company Snapshot
- 8.6.3 Financial Overview
- 8.6.4 Product Listing
- 8.6.5 Entropy
8.7 Medtronic
- 8.7.1 Company Overview
- 8.7.2 Company Snapshot
- 8.7.3 Financial Overview
- 8.7.4 Product Listing
- 8.7.5 Entropy
8.8 Well Lead Medical Co., Ltd.
- 8.8.1 Company Overview
- 8.8.2 Company Snapshot
- 8.8.3 Financial Overview
- 8.8.4 Product Listing
- 8.8.5 Entropy
8.9 Smiths Medical
- 8.9.1 Company Overview
- 8.9.2 Company Snapshot
- 8.9.3 Financial Overview
- 8.9.4 Product Listing
- 8.9.5 Entropy
8.10. BACTIGUARD AB
- 8.10.1 Company Overview
- 8.10.2 Company Snapshot
- 8.10.3 Financial Overview
- 8.10.4 Product Listing
- 8.10.5 Entropy
8.11. Shenzhen Prunus Medical Co., Ltd.
- 8.11.1 Company Overview
- 8.11.2 Company Snapshot
- 8.11.3 Financial Overview
- 8.11.4 Product Listing
- 8.11.5 Entropy
8.12. Optimum Medical Limited
- 8.12.1 Company Overview
- 8.12.2 Company Snapshot
- 8.12.3 Financial Overview
- 8.12.4 Product Listing
- 8.12.5 Entropy
8.13. Angiplast
- 8.13.1 Company Overview
- 8.13.2 Company Snapshot
- 8.13.3 Financial Overview
- 8.13.4 Product Listing
- 8.13.5 Entropy
8.14. Guangzhou Orcl Medical Co., Ltd.
- 8.14.1 Company Overview
- 8.14.2 Company Snapshot
- 8.14.3 Financial Overview
- 8.14.4 Product Listing
- 8.14.5 Entropy
8.15. Apollon Co., Ltd.
- 8.15.1 Company Overview
- 8.15.2 Company Snapshot
- 8.15.3 Financial Overview
- 8.15.4 Product Listing
- 8.15.5 Entropy
8.16. The Flume Catheter Company
- 8.16.1 Company Overview
- 8.16.2 Company Snapshot
- 8.16.3 Financial Overview
- 8.16.4 Product Listing
- 8.16.5 Entropy
8.17. MEDADV Medical
- 8.17.1 Company Overview
- 8.17.2 Company Snapshot
- 8.17.3 Financial Overview
- 8.17.4 Product Listing
- 8.17.5 Entropy
8.18. Otsuka Pharmaceutical Factory, Inc.
- 8.18.1 Company Overview
- 8.18.2 Company Snapshot
- 8.18.3 Financial Overview
- 8.18.4 Product Listing
- 8.18.5 Entropy
8.19. CATHETRIX
- 8.19.1 Company Overview
- 8.19.2 Company Snapshot
- 8.19.3 Financial Overview
- 8.19.4 Product Listing
- 8.19.5 Entropy
8.20. Flume Catheter Company
- 8.20.1 Company Overview
- 8.20.2 Company Snapshot
- 8.20.3 Financial Overview
- 8.20.4 Product Listing
- 8.20.5 Entropy